Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18 (original) (raw)
- Zhonghao Liu,
- Jingsong Xu,
- Jennifer S. Colvin, and
- David M. Ornitz1
- Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, Missouri 63110, USA
Abstract
Gain of function mutations in fibroblast growth factor (FGF) receptors cause chondrodysplasia and craniosynostosis syndromes. The ligands interacting with FGF receptors (FGFRs) in developing bone have remained elusive, and the mechanisms by which FGF signaling regulates endochondral, periosteal, and intramembranous bone growth are not known. Here we show that Fgf18 is expressed in the perichondrium and that mice homozygous for a targeted disruption of_Fgf18_ exhibit a growth plate phenotype similar to that observed in mice lacking Fgfr3 and an ossification defect at sites that express Fgfr2. Mice lacking either Fgf18 or_Fgfr3_ exhibited expanded zones of proliferating and hypertrophic chondrocytes and increased chondrocyte proliferation, differentiation, and Indian hedgehog signaling. These data suggest that FGF18 acts as a physiological ligand for FGFR3. In addition, mice lacking_Fgf18_ display delayed ossification and decreased expression of osteogenic markers, phenotypes not seen in mice lacking_Fgfr3_. These data demonstrate that FGF18 signals through another FGFR to regulate osteoblast growth. Signaling to multiple FGFRs positions FGF18 to coordinate chondrogenesis in the growth plate with osteogenesis in cortical and trabecular bone.
Footnotes
↵1 Corresponding author.
E-MAIL dornitz{at}molecool.wustl.edu; FAX (314) 362-7058.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.965602.
- Received November 28, 2001.
- Accepted February 14, 2002.
Cold Spring Harbor Laboratory Press
